Provided by Tiger Trade Technology Pte. Ltd.

INSILICO

52.100
-1.800-3.34%
Volume:1.54M
Turnover:79.96M
Market Cap:30.37B
PE:-11.63
High:53.350
Open:53.350
Low:51.200
Close:53.900
52wk High:80.900
52wk Low:29.980
Shares:583.00M
HK Float Shares:583.00M
Volume Ratio:4.90
T/O Rate:0.26%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-4.480
ROE:--
ROA:-1.36%
PB:7.08
PE(LYR):-11.63
PS:28.67

Loading ...

Movement Alert|Insilico Medicine Falls 6.32% in Regular Trading, Post-Takeda Deal Selling Pressure Persists

Market Focus
·
Jul 03

PRESS Digest -wall Street Journal - July 2

Reuters
·
Jul 02

Insilico Medicine Announces Collaboration with Takeda to Advance Strategic AI Drug Discovery

THOMSON REUTERS
·
Jul 02

Insilico Medicine Cayman Topco: Total Deal Value to Approximately $600 Mln

THOMSON REUTERS
·
Jul 02

Movement Alert|Insilico Medicine Rises 5.81% in Regular Trading, Strategic Collaboration with Takeda Worth Up to $600 Million

Market Focus
·
Jul 02

Insilico Medicine Announces Strategic Collaboration with Takeda for AI-Driven Drug Discovery

Stock News
·
Jul 02

Insilico Medicine and Takeda Sign AI-Driven Drug Discovery Deal Worth up to USD600 million

Bulletin Express
·
Jul 02

Insilico Medicine Cayman Announces Drug Discovery Collaboration with Takeda Worth up to $600 Million

Reuters
·
Jul 02

Insilico Medicine Cayman Topco - Takeda Granted Exclusive Worldwide Rights to Develop and Commercialize Collaboration Therapeutics

THOMSON REUTERS
·
Jul 02

Insilico Medicine Cayman Topco - Deal Value up to Usd600 Mln Including USD60 Mln in Upfront and Near-term Payments

THOMSON REUTERS
·
Jul 02

Insilico Medicine Cayman Topco - Voluntary Announcement Insilico Medicine and Takeda Achieved Strategic Ai-powered Drug Discovery Collaboration Worth up to Usd600 Mln

THOMSON REUTERS
·
Jul 02

Takeda Will be Granted Exclusive Worldwide Rights Under Insilico Deal to Develop, Manufacture and Commercialize New Drugs - WSJ

THOMSON REUTERS
·
Jul 02

Takeda, Insilico Strike AI Drug-discovery Deal Worth up to $600.0 Million

Dow Jones
·
Jul 02

Insilico Leadership Voluntarily Extends Share Lock-Up Period

Stock News
·
Jun 30

Movement Alert|Insilico Medicine Falls 11.12% in Regular Trading, Massive Lock-up Share Expiry Triggers Concentrated Selling Pressure

Market Focus
·
Jun 30

Movement Alert|Insilico Medicine Falls 5.7% in Regular Trading, Selling Pressure Intensifies Ahead of Massive Lock-Up Expiry

Market Focus
·
Jun 29

Movement Alert|Insilico Medicine Falls 5.76% in Regular Trading, Profit-Taking Intensifies Ahead of Massive Lock-Up Expiry

Market Focus
·
Jun 26

Movement Alert|Insilico Medicine Rises 5.64% in Regular Trading, SK Biopharmaceuticals $2.5 Billion AI-Driven Collaboration Continues to Fuel Rally

Market Focus
·
Jun 25

Movement Alert|Insilico Medicine Rises 6.34% in Regular Trading, SK Biopharmaceuticals USD 2.5 Billion AI-Driven Collaboration Continues to Fuel Rally

Market Focus
·
Jun 24

Movement Alert|Insilico Medicine Rises 5.95% in Regular Trading, SK Biopharmaceuticals USD 2.5 Billion AI-Driven Collaboration Continues to Boost Sentiment

Market Focus
·
Jun 23